Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of recombinant full length human CDK16/cyclinY at 10 uM using PKSPKARKKL as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human CDK17/cyclin-Y assessed as residual activity at 100 uM using MBP protein as substrate by [gamma-33P]-ATP assay relative to control
Inhibition of human CDK18/cyclin-Y assessed as residual activity at 100 uM using RB protein as substrate by [gamma-33P]-ATP assay relative to control
Inhibition of human CDK14/cyclin-Y using RB protein as substrate by [gamma-33P]-ATP assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human CDK16/cyclin-Y using RB protein as substrate by [gamma-33P]-ATP assay
Inhibition of human CDK17/cyclin-Y using MBP protein as substrate by [gamma-33P]-ATP assay
Inhibition of human CDK18/cyclin-Y using RB protein as substrate by [gamma-33P]-ATP assay
Inhibition of recombinant full length human CDK14/cyclinY assessed as residual activity at 1 uM in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Assay data:2 Tested
Inhibition of recombinant full length human CDK16/cyclinY assessed as residual activity at 1 uM using PKSPKARKKL as substrate incubated for 120 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Inhibition of recombinant full length human CDK17/cyclinY assessed as residual activity at 1 uM using PKSPKARKKL as substrate incubated for 120 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Inhibition of recombinant full length human CDK18 /cyclinY T166M mutant assessed as residual activity at 1 uM using YRRAAVPPSPSLS as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Inhibition of recombinant full length human CDK14/cyclinY assessed as residual activity at 10 uM in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Inhibition of recombinant full length human CDK16/cyclinY assessed as residual activity at 10 uM using PKSPKARKKL as substrate incubated for 120 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Inhibition of recombinant full length human CDK17/cyclinY assessed as residual activity at 10 uM using PKSPKARKKL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Inhibition of recombinant full length human CDK18/cyclinY T166M mutant assessed as residual activity at 10 uM using YRRAAVPPSPSLS as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Inhibition of human CDK16/cyclin-Y assessed as residual activity at 100 uM using RB protein as substrate by [gamma-33P]-ATP assay relative to control
Inhibition of human CDK14/cyclinY at 10 uM by radiometric method
Inhibition of human CDK17/cyclinY at 10 uM using PKSPKARKKL as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method
Inhibition of recombinant full length human cyclinY/CDK18 T166M mutant at 10 uM using YRRAAVPPSPSLS as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method
Inhibition of human CDK14/cyclin-Y at 100 nM using RB protein as substrate by [gamma-33P]-ATP assay
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on